Centessa Pharmaceuticals plc (CNTA)

Centessa Pharmaceuticals Market Cap

Centessa Pharmaceuticals has a market cap or net worth of $889.27 million as of May 17, 2024. Its market cap has increased by 102.24% in one year.

• Market Cap: 889.27M
• Enterprise Value: 744.63M
• 1-Year Change: 102.24%
• Ranking: #2543
• Category: Small-Cap
• Stock Price: $8.87

Market Cap Chart

Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has decreased from $1.75B to $889.27M, a decrease of -49.14%. That is a compound annual growth rate of -20.34%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	1.00B	-0.89%
May 16, 2024	1.01B	1.81%
May 15, 2024	993.70M	-2.76%
May 14, 2024	1.02B	2.37%
May 13, 2024	998.20M	10.95%
May 10, 2024	899.70M	-6.08%
May 9, 2024	957.90M	0.74%
May 8, 2024	950.90M	-1.97%
May 7, 2024	970.00M	4.55%
May 6, 2024	927.80M	-2.33%
May 3, 2024	949.90M	-0.84%
May 2, 2024	957.90M	0.74%
May 1, 2024	950.90M	3.49%
Apr 30, 2024	918.80M	-1.40%
Apr 29, 2024	931.80M	4.15%
Apr 26, 2024	894.70M	-0.11%
Apr 25, 2024	895.70M	-5.61%
Apr 24, 2024	948.90M	0.64%
Apr 23, 2024	942.90M	-6.00%
Apr 22, 2024	1.00B	-5.39%
Apr 19, 2024	1.06B	0.38%
Apr 18, 2024	1.06B	-2.32%
Apr 17, 2024	1.08B	-2.27%
Apr 16, 2024	1.11B	2.32%
Apr 15, 2024	1.08B	-4.77%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
OPKO Health	940.94M
Liquidia	938.74M
Pliant Therapeutics	926.60M
Perspective Therapeutics	921.46M
Avanos Medical	919.46M
Viridian Therapeutics	910.75M
ProKidney	910.31M
89bio	905.13M